OTC · Financial Statements
Molecular Partners AG (MLLCF) Financial Statements
$3.80
OTC: MLLCF
Market Cap $142.54M
Overview Financials Dividend
Molecular Partners AG most recently reported annual revenue of $0, a net loss of $62.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $9.0M $190.0M $7.0M $5.0M $0 Operating Profit $-63.0M $117.0M $-61.0M $-61.0M $-55.0M Net Profit $-64.0M $118.0M $-62.0M $-54.0M $-62.0M EPS $-2.06 $3.54 $-1.89 $-1.63 $-1.65 Op Margin -679.7% 61.5% -868.3% -1231.7% —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $173.0M $262.0M $198.0M $159.0M $102.0M Total Liabilities $65.0M $27.0M $22.0M $17.0M $22.0M Cash $72.0M $88.0M $67.0M $64.0M $93.0M Borrowings $6.0M $5.0M $4.0M $2.0M $4.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-91.0M $119.0M $-59.0M $-59.0M $-50.0M Investing Cash Flow $-24.0M $-103.0M $44.0M $40.0M $70.0M Financing Cash Flow $0 $0 $0 $-2.0M $0 Net Cash Flow $-62.0M $16.0M $-21.0M $-3.0M $-37.0M Free Cash Flow $-92.0M $117.0M $-60.0M $-60.0M $-50.0M
Valuation & Return Ratios
Metric Value PEG Ratio — EV / EBITDA — FCF Yield -35.08% Quick Ratio 9.42 Interest Coverage -13.75 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .